VTGN Analysis

VistaGen Therapeutics, Inc.
Stock Exchange: NASDAQ
Sector: healthcare
1.19
Last session price
1.19
Price now
Currency: USD
Reporting currency: USD
ISIN: US92840H2022
INN:
.

VTGN financial statements

* Numbers in thousands
Capitalization * 102 499
EV * 118 528
Number of shares * 86 134
EPS -0,21
Revenue * 1 090
Net income * -17 934
Operating profit * -17 934
Total liabilities * 16 303
Net debt * -99 390
Total assets * 108 281
Equity * 91 979
Cash and investments * 103 108
.

VTGN valuation

P/E -5,72
P/B 1,11
P/S 94,08
E/P -18
P/FCF -8,30
.

VTGN profitability

ROE -20%
ROA% -17%
ROIC% -17%